Literature DB >> 17266203

Synthesis and characterization of potent and selective mu-opioid receptor antagonists, [Dmt(1), D-2-Nal(4)]endomorphin-1 (Antanal-1) and [Dmt(1), D-2-Nal(4)]endomorphin-2 (Antanal-2).

Jakub Fichna1, Jean-Claude do-Rego, Nga N Chung, Carole Lemieux, Peter W Schiller, Jeroen Poels, Jozef Vanden Broeck, Jean Costentin, Anna Janecka.   

Abstract

To synthesize potent antagonists of the mu-opioid receptor, we prepared a series of endomorphin-1 and endomorphin-2 analogues with 3-(1-naphthyl)-d-alanine (d-1-Nal) or 3-(2-naphthyl)-d-alanine (d-2-Nal) in position 4. Some of these analogues displayed weak antagonist properties. We tried to strengthen these properties by introducing the structurally modified tyrosine residue 2,6-dimethyltyrosine (Dmt) in place of Tyr1. Among the synthesized compounds, [Dmt1, d-2-Nal4]endomorphin-1, designated antanal-1, and [Dmt1, d-2-Nal4]endomorphin-2, designated antanal-2, turned out to be highly potent and selective mu-opioid receptor antagonists, as judged on the basis of two functional assays, the receptor binding assay and the hot plate test of analgesia. Interestingly, another analogue of this series, [Dmt1, d-1-Nal4]endomorphin-1, turned out to be a moderately potent mixed mu-agonist/delta-antagonist.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17266203     DOI: 10.1021/jm060998u

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  9 in total

1.  Development and in vitro characterization of a novel bifunctional μ-agonist/δ-antagonist opioid tetrapeptide.

Authors:  Lauren C Purington; Katarzyna Sobczyk-Kojiro; Irina D Pogozheva; John R Traynor; Henry I Mosberg
Journal:  ACS Chem Biol       Date:  2011-10-11       Impact factor: 5.100

2.  Synthesis and evaluation of new endomorphin-2 analogues containing (Z)-alpha,beta-didehydrophenylalanine (Delta(Z)Phe) residues.

Authors:  Domenica Torino; Adriano Mollica; Francesco Pinnen; Federica Feliciani; Gino Lucente; Giancarlo Fabrizi; Gustavo Portalone; Peg Davis; Josephine Lai; Shou-Wu Ma; Frank Porreca; Victor J Hruby
Journal:  J Med Chem       Date:  2010-06-10       Impact factor: 7.446

3.  Novel opioid peptide derived antagonists containing (2S)-2-methyl-3-(2,6-dimethyl-4-carbamoylphenyl)propanoic acid [(2S)-Mdcp].

Authors:  Animesh Ghosh; Jie Luo; Chen Liu; Grazyna Weltrowska; Carole Lemieux; Nga N Chung; Yixin Lu; Peter W Schiller
Journal:  J Med Chem       Date:  2008-09-25       Impact factor: 7.446

4.  Synthesis and evaluation of new endomorphin analogues modified at the Pro(2) residue.

Authors:  Domenica Torino; Adriano Mollica; Francesco Pinnen; Gino Lucente; Federica Feliciani; Peg Davis; Josephine Lai; Shou-Wu Ma; Frank Porreca; Victor J Hruby
Journal:  Bioorg Med Chem Lett       Date:  2009-06-06       Impact factor: 2.823

Review 5.  Molecular Pharmacology of δ-Opioid Receptors.

Authors:  Louis Gendron; Catherine M Cahill; Mark von Zastrow; Peter W Schiller; Graciela Pineyro
Journal:  Pharmacol Rev       Date:  2016-07       Impact factor: 25.468

6.  Development and characterisation of novel fentanyl-delta opioid receptor antagonist based bivalent ligands.

Authors:  M F Bird; R S Vardanyan; V J Hruby; G Calò; R Guerrini; S Salvadori; C Trapella; J McDonald; D J Rowbotham; D G Lambert
Journal:  Br J Anaesth       Date:  2015-02-13       Impact factor: 9.166

7.  The influence of opioids on matrix metalloproteinase-2 and -9 secretion and mRNA levels in MCF-7 breast cancer cell line.

Authors:  Katarzyna Gach; Janusz Szemraj; Anna Wyrębska; Anna Janecka
Journal:  Mol Biol Rep       Date:  2010-06-20       Impact factor: 2.316

Review 8.  Bi- or multifunctional opioid peptide drugs.

Authors:  Peter W Schiller
Journal:  Life Sci       Date:  2009-03-11       Impact factor: 5.037

9.  New type of BACE1 siRNA delivery to cells.

Authors:  Maciej Jabłkowski; Maciej Szemraj; Katarzyna Oszajca; Grażyna Janiszewska; Jacek Bartkowiak; Janusz Szemraj
Journal:  Med Sci Monit       Date:  2014-12-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.